| Term 
 
        | Name 5 HMG-CoA Reductase Inhibitors (Statins) |  | Definition 
 
        | -Atorvastatin -Fluvastatin
 -Lovastatin
 -Pravastatin
 -Simvastatin
 |  | 
        |  | 
        
        | Term 
 
        | What is the mechanism of action of the Statins? |  | Definition 
 
        | They inhibit the HMG-CoA reductase enzyme in the liver, leading to a decrease in serum cholesterol and LDL concentration. |  | 
        |  | 
        
        | Term 
 
        | What is a contraindication of the Statins? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Headache -Myalgia (muscle pain)
 -Liver damage
 -GI irritation
 |  | 
        |  | 
        
        | Term 
 
        | What are the nursing considerations when administering Statins? |  | Definition 
 
        | -Give in the evening to coincide with body's timing of cholesterol production -Perform liver function test
 -Follow-up at regular intervals
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Cholestyramine resin -Colestipol
 |  | 
        |  | 
        
        | Term 
 
        | What is the mechanism of action of the Bile Acid Resins? |  | Definition 
 
        | They bind with bile acids in the Gi tract. |  | 
        |  | 
        
        | Term 
 
        | What are 2 contraindications of the Bile Acid Resins? |  | Definition 
 
        | -Pediatrics -Biliary obstruction
 |  | 
        |  | 
        
        | Term 
 
        | ADRs of Bile Acid Resins (2) |  | Definition 
 
        | -Steatorrhea (excess fat in feces) -Fat-soluble vitamin deficiencies
 |  | 
        |  | 
        
        | Term 
 
        | What are the nursing considerations when administering Bile Acid Resins? |  | Definition 
 
        | Mix with full glass of water and do not administer with other medications. |  | 
        |  | 
        
        | Term 
 
        | What are cardiovascular diseases and how are they caused? |  | Definition 
 
        | Usually refers to atherosclerosis. It is caused by a build up of fatty materials such as cholesterol in the artery wall. |  | 
        |  | 
        
        | Term 
 
        | Name 2 Fibric Acid Derivatives. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is the mechanism of action of Fibric Acid Derivatives? |  | Definition 
 
        | They suppress VLDL and chlyomicron synthesis resulting in a reduction of triglyceride levels. |  | 
        |  | 
        
        | Term 
 
        | What are the contraindications of Fibric Acid Derivatives (2)? |  | Definition 
 
        | -Gallbladder disease -Liver or biliary cirrhosis
 |  | 
        |  | 
        
        | Term 
 
        | Name 1 Nicotinic Acid Derivative. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is the mechanism of action of Niacin? |  | Definition 
 
        | The mechanism of action of niacin is unclear. |  | 
        |  | 
        
        | Term 
 
        | What are the contraindications of Niacin (2)? |  | Definition 
 
        | -Liver disease -Severe hypotension
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Flushing -Itching
 -Orthostatic hypotension
 -GI irritation
 |  | 
        |  | 
        
        | Term 
 
        | What are the nursing considerations when administering Niacin? |  | Definition 
 
        | Alcohol should be avoided as it increases flushing. |  | 
        |  | 
        
        | Term 
 
        | Name 1 Cholesterol Absorption Inhibitor. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is the mechanism of action of Ezetimibe? |  | Definition 
 
        | It decrease the amount of cholesterol absorbed in the GI tract. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Diarrhea -Arthralgia (joint pain)
 |  | 
        |  | 
        
        | Term 
 
        | What are the nursing considerations when administering Ezetimibe? |  | Definition 
 
        | Monitor coagulation studies if patient is also receiving warfin. |  | 
        |  | 
        
        | Term 
 
        | Name 1 Lipid-Regulating Agent. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is the mechanism of action of omega-3-triglycerides? |  | Definition 
 
        | They disrupt triglyceride synthesis. |  | 
        |  | 
        
        | Term 
 
        | Contraindications of Omega-3-Triglycerides (1) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ADRs of Omega-3-Triglycerides (2) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are the nursing considerations when administering Omega-3-Triglycerides? |  | Definition 
 
        | They may potentiate anticoagulants. Monitor coagulation studies. |  | 
        |  |